Drug major Cipla Ltd posted net profit of Rs 257.4 crore for the quarter ended June, 6.5 per cent higher as compared to Rs241.7 crore in the same quarter last year, thanks to better exports and sales.
Total sales were higher by 7.6 per cent, at Rs 1,441 crore as compared to Rs1,339.5 crore for the previous year’s quarter. Other operating income was higher by 7.6 per cent, at Rs 52.4 crore.
Cipla exported drugs worth Rs 765.9 crore for the period, 11.4 per cent higher than the Rs 687.6 crore worth of exports in the previous year’s quarter.